Roche (RHHBY) PT Lowered to $46 at Morgan Stanley

April 7, 2026 10:28 AM

Morgan Stanley analyst Sarita Kapila lowered the price target on Roche (OTC: RHHBY) to $46.00 (from $48.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found